These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
265 related items for PubMed ID: 31293986
1. Cepharanthine Hydrochloride Improves Cisplatin Chemotherapy and Enhances Immunity by Regulating Intestinal Microbes in Mice. Zhou P, Li Z, Xu D, Wang Y, Bai Q, Feng Y, Su G, Chen P, Wang Y, Liu H, Wang X, Zhang R, Wang Y. Front Cell Infect Microbiol; 2019; 9():225. PubMed ID: 31293986 [Abstract] [Full Text] [Related]
2. Toll-like receptors in the pathogenesis of chemotherapy-induced gastrointestinal toxicity. Cario E. Curr Opin Support Palliat Care; 2016 Jun; 10(2):157-64. PubMed ID: 26986508 [Abstract] [Full Text] [Related]
8. eIF4E promotes tumorigenesis and modulates chemosensitivity to cisplatin in esophageal squamous cell carcinoma. Liu T, Li R, Zhao H, Deng J, Long Y, Shuai MT, Li Q, Gu H, Chen YQ, Leng AM. Oncotarget; 2016 Oct 11; 7(41):66851-66864. PubMed ID: 27588477 [Abstract] [Full Text] [Related]
9. Induction of autophagy counteracts the anticancer effect of cisplatin in human esophageal cancer cells with acquired drug resistance. Yu L, Gu C, Zhong D, Shi L, Kong Y, Zhou Z, Liu S. Cancer Lett; 2014 Dec 01; 355(1):34-45. PubMed ID: 25236911 [Abstract] [Full Text] [Related]
10. Metformin inhibited esophageal squamous cell carcinoma proliferation in vitro and in vivo and enhanced the anti-cancer effect of cisplatin. Wang F, Ding X, Wang T, Shan Z, Wang J, Wu S, Chi Y, Zhang Y, Lv Z, Wang L, Fan Q. PLoS One; 2017 Dec 01; 12(4):e0174276. PubMed ID: 28406985 [Abstract] [Full Text] [Related]
11. TLR signaling modulates side effects of anticancer therapy in the small intestine. Frank M, Hennenberg EM, Eyking A, Rünzi M, Gerken G, Scott P, Parkhill J, Walker AW, Cario E. J Immunol; 2015 Feb 15; 194(4):1983-95. PubMed ID: 25589072 [Abstract] [Full Text] [Related]
12. The HSP90 inhibitor 17-N-allylamino-17-demethoxy geldanamycin (17-AAG) synergizes with cisplatin and induces apoptosis in cisplatin-resistant esophageal squamous cell carcinoma cell lines via the Akt/XIAP pathway. Ui T, Morishima K, Saito S, Sakuma Y, Fujii H, Hosoya Y, Ishikawa S, Aburatani H, Fukayama M, Niki T, Yasuda Y. Oncol Rep; 2014 Feb 15; 31(2):619-24. PubMed ID: 24317439 [Abstract] [Full Text] [Related]
15. Curcumin potentiates the antitumor effects of 5-FU in treatment of esophageal squamous carcinoma cells through downregulating the activation of NF-κB signaling pathway in vitro and in vivo. Tian F, Fan T, Zhang Y, Jiang Y, Zhang X. Acta Biochim Biophys Sin (Shanghai); 2012 Oct 15; 44(10):847-55. PubMed ID: 23017833 [Abstract] [Full Text] [Related]
20. Notch pathway inhibition using DAPT, a γ-secretase inhibitor (GSI), enhances the antitumor effect of cisplatin in resistant osteosarcoma. Dai G, Deng S, Guo W, Yu L, Yang J, Zhou S, Gao T. Mol Carcinog; 2019 Jan 15; 58(1):3-18. PubMed ID: 29964327 [Abstract] [Full Text] [Related] Page: [Next] [New Search]